News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Rash Management

EP. 1: Managing EGFR Inhibitor Associated Skin Toxicity

October 27th 2013

EP. 2: Anticipatory Coping in Patients Treated With EGFR Inhibitors

October 27th 2013

EP. 3: Managing Angiogenesis Inhibitor Related Skin Toxicity

October 27th 2013

EP. 4: Managing BCR-ABL Inhibitor Associated Skin Rash

October 27th 2013

EP. 5: Managing Treatment-Related Hand-Foot Skin Reaction

October 27th 2013

EP. 6: Interdisciplinary Approach to Managing Skin Toxicities

October 27th 2013

EP. 7: Managing mTOR Inhibitor Induced Adverse Events

October 27th 2013

EP. 8: The Nurse's Role in Managing Skin Toxicity

October 27th 2013

EP. 9: Managing BRAF Inhibitor Associated Skin Toxicity

October 27th 2013

EP. 10: The Role of Patient Education in Side Effect Management

October 27th 2013

EP. 11: Side Effect Management With Corticosteroids

October 27th 2013

Trending on OncLive

Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma

Adagrasib Plus Cetuximab Misses OS, PFS End Points in Pretreated KRAS G12C–Mutated CRC

FDA Issues CRL to Orviglance for Liver Metastasis Imaging in Patients With Severe Kidney Impairment

Phase 1 Data Highlight Potential Utility for In Vivo CAR T-Cell Therapy in R/R Myeloma

Dr Spencer on Differentiating Factors for In Vivo CAR T-Cell Therapy in Myeloma